Key facts
- VoxlBio’s last known valuation is $2.9M (Jan 2024).
- It has raised $490K; the latest was Early Stage VC in Jan 2025.
- Notable investors include Almi Invest, DRIVE ( KI Innovations Business Incubator), Life Science Invest, SU Holding.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for VoxlBio
- ·The full record, as it builds
Funding rounds
No funding rounds for VoxlBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VoxlBio
Developer of genetic spatial analysis technologies intended to visualize genes and mutations as biomarkers within intact tissue at single-cell resolution. The company develops high-throughput spatial genomics tools and analytics, enabling researchers to advance disease understanding and uncover new therapeutic targets.
- Sector
- Healthcare
- HQ
- Solna, Sweden
- Founded
- 2024
- Employees
- 8
- Website
- voxlbio.com/
- Ownership
- Privately Held (backing)
VoxlBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VoxlBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VoxlBio in its N-PORT filings yet. We sweep new filings monthly.